ER
EyeMacular Regeneration, Inc.
SEC filingBiotechnology · St. Paul, MN
Amount raised$2.9Msold at filing
Total offering$6M$3.1M still open
Investors in the raise14count reported to the SEC
FiledSep 25, 2026first sale Oct 8, 2024
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
David C. HermanDirector
Michael Lindsay OlsenDirector
Virginia W OlsenExecutive Officer
Timothy W OlsenExecutive Officer, Director
Richard L. LindstromDirector
Gerald R. BenjaminDirector
David M. BrownDirector
Executive officers, directors and promoters as listed on the Form D.